申请人:——
公开号:US20020147338A1
公开(公告)日:2002-10-10
The present invention relates to pyrazolotriazines according to formula (I)
1
and stereoisomers, isomers and salts thereof wherein R
1
-R
5
are selected from certain alkyl, aryl and heteroaryl species as defined in the specification wherein all of the compounds are useful as CRF antagonists and are thus useful in the treatment of neurological disorders as well as a multitude of other CRF associated diseases or conditions.
本发明涉及按照公式(I)1及其立体异构体、同分异构体和盐所选择的R1-R5从特定烷基、芳基和杂环芳基物种中选择,如规范中所定义,其中所有化合物均可用作CRF拮抗剂,因此在治疗神经系统疾病以及多种其他与CRF相关的疾病或症状中有用。